ONCO-CHIP · Lab-on-a-chip based analyzers for point-of-care monitoring of cancer therapy
6РП — Действия „Мария Кюри“
- Период
- 2006-11-01 → 2008-10-31
- Финансиране от ЕС
- 161 621 €
- Участници
- 1
- Схема
- EIF
Линиите свързват координатора с партньорите.
Накратко на български
Микрофлуидни чипове за анализ на кръв и тъкани помагат за следене на терапията при рак. Тези устройства позволяват бързо почистване и концентриране на пробите, което подобрява точността на мониторинга на пациентите.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Final Activity Report Summary - ONCO-CHIP (Lab-on-a-Chip Based Analyzers for Point-of-Care Monitoring of Cancer Therapy)
The overarching objective of this fellowship was to provide the beneficiary with research training and experience in the field of nanobiotechnology, i.e. microfabrication techniques, lab-on-a-chip (LOC), sensing technologies, biochips etc. To this end, the research theme initially focussed on the development of LOC technologies as a vehicle to provide the fundamental and multidisciplinary skills associated with nanobiotechnology. Achievements from this period included the design and fabrication of a LOC device using wet chemistry etch techniques in soda lime glass substrates. The final LOC device design was capable of incorporating a stationary phase separation column, such as restricted access media (RAM), for simultaneous on-chip sample clean-up and pre-concentration. Preliminary experimental findings were beneficial for understanding the scientific challenges involved in the integration of such technologies and identifying viable solutions to achieve this work objectives. In addition, during this time the fellow contributed to the supervision of a Master of engineering student on a project that produced preliminary data and identified potential techniques for low temperature soda lime glass bonding of microfluidic devices that incorporated integrated optical components, i.e. waveguides. The fellow also collaborated, for the data interpretation and dissemination of results, with a project team involved in the development of a high-precision instrument for automated microcontact printing on microscope slides. This instrument was capable of precisely guiding a stamp until it made contact to the substrate with the absolute position of resultant micro-printed patterns being reproducible over a series of substrates with 1 µm standard deviation. The developed instrument was a compact, low cost instrument with many possibilities to facilitate automated microcontact printing operation in the domains of nanobiotechnology, surface chemistry and microfluidics. Later, the theme of research shifted to biochip technologies. One project aimed to characterise chemical and biological functionalised gold-coated supports for use in surface plasmon resonance (SPR) imaging. This was achieved by investigation of the chip surface topography via atomic force microscopy (AFM) imaging and assessment of the viability of surface functionalisation via colorimetric enzyme-linked immunosorbent assay (ELISA assay). ELISA results confirmed that biomolecules were present and active on the supports, indicating that chemical and biological functionalisation techniques were successful. It appeared possible to differentiate between biochips from different sources and major sources of variability measurements were identified and, in case possible, compensated for. AFM imaging results revealed that topography did not appear to be a factor in the SPR performance of these tested supports and that no correlation existed between efficacy of surface functionalisation and topographical parameters. A second project aimed to develop a bio-barcode assay for platelet genotyping on deoxyribonucleic acid (DNA) that was simpler and more efficient than conventional methods, thereby making it suitable for point-of-care application, e.g. emergency rooms. Bio-barcodes yielded a many fold amplification of the target molecule using technology which was based upon magnetic microparticles and gold nanoparticles. The obtained results included optimisation of protocol and proof-of-concept for its various elements.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
The objective is to develop advanced disposable chips, for point-of-care multi-parametric analysis of protein cancer markers. It is important to note that monitoring of multiple markers is essential to improve the reliability and the specificity of the analysis.The complete analytical instruments will comprise of disposable chips and a control unit, with dimensions of a credit card and book respectively. The essential functional blocks needed for sample preparation and analysis will be developed and integrated into a single chip.This includes such functions as the extraction of the serum from a drop of blood, protein pre-purification and pre-concentration and immuno-electrochromatographic separation, to assess quantitatively the cancer markers of interest. The final detection of the concentration of cancer markers will be based on integrated optical components (optical guides, Y-junctions) implemented in the chip and coupled with micro-fluidic channels.This integrated optical system will be used for guiding the excitation light on the chip, excitation of a fluorescence signal at the end of several separation micro-channels and for collection of the fluorescence response. The developed technology (chips + control unit) will be inexpensive, autonomous, and straightforward in its operation and interpretation.It will provide a new platform capable of performing frequent and cost-effective monitoring of tumour biomarkers at the point-of-care or in small analytical laboratories. This will improve the comfort of life of cancer patients and allow a more efficient therapy management.
Оригинален текст от CORDIS (на английски).
Участници
- ECOLE CENTRALE DE LYON · ECULLYКоординаторФранция
Връзки
Данни: CORDIS, © Европейски съюз
